Abstract
The study was powered to investigate whether there was a difference
from 45% to 60% in 2-year survival rates in patients with early-stage
NSCLC treated with induction chemotherapy followed by surgery
versus a control group of patients receiving primary surgery.
Original language | English |
---|---|
Pages (from-to) | 2603-2604 |
Number of pages | 1 |
Journal | Journal of Clinical Oncology |
Volume | 20 |
Issue number | 10 |
Publication status | Published - 15 May 2002 |
Keywords
- preoperative chemotherapy
- lung cancer
- oncology